Reiter Y - Search Results

1

The Intracellular Proteome as a Source for Novel Targets in CAR-T and T-Cell Engagers-Based Immunotherapy.

Arman I, Haus-Cohen M, Reiter Y. Arman I, et al. Among authors: reiter y. Cells. 2022 Dec 21;12(1):27. doi: 10.3390/cells12010027. Cells. 2022. PMID: 36611821 Free PMC article. Review.

2

MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.

Stroopinsky D, Rosenblatt J, Ito K, Mills H, Yin L, Rajabi H, Vasir B, Kufe T, Luptakova K, Arnason J, Nardella C, Levine JD, Joyce RM, Galinsky I, Reiter Y, Stone RM, Pandolfi PP, Kufe D, Avigan D. Stroopinsky D, et al. Among authors: reiter y. Cancer Res. 2013 Sep 1;73(17):5569-79. doi: 10.1158/0008-5472.CAN-13-0677. Epub 2013 Jul 18. Cancer Res. 2013. PMID: 23867470 Free PMC article.

3

HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.

Meza-Romero R, Benedek G, Yu X, Mooney JL, Dahan R, Duvshani N, Bucala R, Offner H, Reiter Y, Burrows GG, Vandenbark AA. Meza-Romero R, et al. Among authors: reiter y. J Immunol. 2014 May 1;192(9):4164-73. doi: 10.4049/jimmunol.1303118. Epub 2014 Mar 28. J Immunol. 2014. PMID: 24683185 Free PMC article.

4

Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.

Denkberg G, Cohen CJ, Lev A, Chames P, Hoogenboom HR, Reiter Y. Denkberg G, et al. Among authors: reiter y. Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9421-6. doi: 10.1073/pnas.132285699. Epub 2002 Jul 1. Proc Natl Acad Sci U S A. 2002. PMID: 12093904 Free PMC article.

5

Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions.

Cohen CJ, Denkberg G, Lev A, Epel M, Reiter Y. Cohen CJ, et al. Among authors: reiter y. J Mol Recognit. 2003 Sep-Oct;16(5):324-32. doi: 10.1002/jmr.640. J Mol Recognit. 2003. PMID: 14523945 Review.

6

Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope.

Haus-Cohen M, Assaraf YG, Binyamin L, Benhar I, Reiter Y. Haus-Cohen M, et al. Among authors: reiter y. Int J Cancer. 2004 May 1;109(5):750-8. doi: 10.1002/ijc.20037. Int J Cancer. 2004. PMID: 14999785

7

Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody.

Binyamin L, Assaraf YG, Haus-Cohen M, Stark M, Reiter Y. Binyamin L, et al. Among authors: reiter y. Int J Cancer. 2004 Jul 20;110(6):882-90. doi: 10.1002/ijc.20177. Int J Cancer. 2004. PMID: 15170671

8

T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.

Noy R, Eppel M, Haus-Cohen M, Klechevsky E, Mekler O, Michaeli Y, Denkberg G, Reiter Y. Noy R, et al. Among authors: reiter y. Expert Rev Anticancer Ther. 2005 Jun;5(3):523-36. doi: 10.1586/14737140.5.3.523. Expert Rev Anticancer Ther. 2005. PMID: 16250828 Review.

9

Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.

Denkberg G, Reiter Y. Denkberg G, et al. Among authors: reiter y. Autoimmun Rev. 2006 Apr;5(4):252-7. doi: 10.1016/j.autrev.2005.07.004. Epub 2005 Aug 8. Autoimmun Rev. 2006. PMID: 16697965 Review.

10

Novel antibodies as anticancer agents.

Zafir-Lavie I, Michaeli Y, Reiter Y. Zafir-Lavie I, et al. Among authors: reiter y. Oncogene. 2007 May 28;26(25):3714-33. doi: 10.1038/sj.onc.1210372. Oncogene. 2007. PMID: 17530025 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

106 results

Search Page

Filters